Satellos Bioscience Inc. (TSX:MSCL)
9.50
-0.40 (-4.04%)
Oct 14, 2026, 3:56 PM EST
Satellos Bioscience Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Satellos Bioscience stock has a consensus rating of "Buy" and an average price target of $17.47. The average 1-year stock price forecast is 83.89% higher than the current stock price, while the lowest is $16.00 (+68.42%) and the highest is $19.00 (+100.00%).
Price Target: $17.47 (+83.89%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Satellos Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Initiates $34.21 | Buy | Initiates | $34.21 | +260.13% | Oct 8, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $28.51 | Buy | Reiterates | $28.51 | +200.11% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $31.36 | Buy | Reiterates | $31.36 | +230.12% | Oct 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $25.66 | Buy | Maintains | $25.66 | +170.10% | Sep 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $57.02 | Buy | Maintains | $57.02 | +500.22% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
-1.32